ctDNA-Directed Post-Hepatectomy Chemotherapy for Patients With Resectable Colorectal Liver Metastases
Clinical trial NCT05062317 · RECRUITING
Trial details
- NCT number
- NCT05062317
- Sponsor
- M.D. Anderson Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-26
- Primary completion
- 2027-02-28
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.